Increasing Medical Marijuana and Cannabidiol Research

Executive orderRegulation easedSigned 25/12/18Federal Register 25/12/23Executive Order 14370Open the original

Summary

President Trump signs an executive order to increase medical marijuana and cannabidiol research, noting HHS's 2023 recommendation to move marijuana from Schedule I to Schedule III of the Controlled Substances Act.

By industry

This announcement is not tied to any industry.

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

No member or insider traded these stocks in that window.